by Scott Larrivee | Nov 12, 2025 | News, Utah
Company’s radioisotope production platform recognized for potential impact on next-generation cancer diagnostics and therapeutics Members of the Nusano team celebrate the Innovation Impact Award at the Utah Life Sciences Summit in Salt Lake City on November 12. 2025....
by Scott Larrivee | Nov 12, 2025 | Blog
Innovation in Critical Mineral Mining and Processing Must Be a National Priority CHRIS LOWECEO, Nusano Follow To control our own destiny, the United States needs nothing short of a Declaration of Critical Minerals Independence. Government, private industry and...
by Scott Larrivee | Nov 6, 2025 | Blog
Nov. 6, 2025 – Nusano CEO, Chris Lowe, is the featured guest on the new edition of the Healthcare Technology Report podcast with RJ Lumba. The two discuss: Nusano’s breakthrough radioisotope production platform; The company’s endeavors beyond life...
by Scott Larrivee | Nov 6, 2025 | Blog, Utah
SALT LAKE CITY – Nov. 5, 2025 – Nusano is honored to receive the 2025 Innovation Impact Award from BioUtah. The award recognizes organizations making an indelible mark on Utah’s life sciences community. BioUtah writes: “We are proud to recognize this...
by Scott Larrivee | Oct 16, 2025 | News
The following is a copy of a press release issued by Clarity Pharmaceuticals Sydney, Australia 16 October 2025 Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products...
